http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1280532-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ffa3f9d6b87e15e0a1551fb129b531
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
filingDate 2001-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b07632a4baddd6b80fcd1c302a0f613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b5a72625332be1787c577c0fc059db0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_011ee9dc4568f024620d722ad84d65e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_742ae302b917d2bedd33b19b3cd86c2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12a57dbcd6203e5c3e1892984c79c325
publicationDate 2003-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1280532-A1
titleOfInvention Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
abstract The invention discloses formulations for administration through pressurized metered dose inhalers containing as active ingredient a glucocorticoid, in particular the (22R) epimer of budesonide, in solution in a hydrofluorocarbon propellant, a cosolvent and a suitable additive, and their use in the treatment of asthma and other bronchopulmonary disorders.
priorityDate 2000-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426105758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18518863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546554
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127699226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136098781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396156
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420105
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67940
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129749464
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129788408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359268

Total number of triples: 55.